# Lung Cancer
Latest news and articles about Lung Cancer
Total: 5 articles found
The New Vanguard: China’s Biotechs Shift from Mimicry to Mastery at ASCO 2026
China has achieved a record-breaking presence at the 2026 ASCO conference, securing nearly 20% of the world's Late-Breaking Abstracts. This surge reflects a decade-long transition from generic drug manufacturing to leading-edge oncology innovation in fields like ADCs and bispecific antibodies.
China’s Oncology Frontier: Bioken’s Breakthrough Signals New Global Standard in Lung Cancer Treatment
Chinese biotech firm Bioken has reported record-breaking Phase II clinical results for its bispecific ADC lung cancer treatment, achieving a 100% tumor shrinkage rate in target lesions. Backed by a historic $8.4 billion deal with Bristol Myers Squibb, the company’s success highlights China’s rapid ascent from a generic drug producer to a leader in original pharmaceutical innovation.
Precision Oncology Gains Ground in China: AmoyDx Secures Regulatory Nod for c-Met Lung Cancer Diagnostic
Amoy Diagnostics has received NMPA approval for its c-Met gene amplification kit, a companion diagnostic for the lung cancer drug Savolitinib. This development marks a vital step in China's push for localized precision oncology and sophisticated personalized medicine tools.
Healing the Frontline: Why a Military Doctor's Empathy is Resonating Across China
The viral story of military doctor Dai Jigang's empathetic care highlights the systemic pressures of China's healthcare system and the unique role of military medicine in maintaining public trust. By offering both in-person and digital consultations, Dai addresses the massive rural-urban divide in medical access.
Beyond the Scalpel: A Military Doctor and the Human Face of China’s Healthcare Strain
Military doctor Dai Jigang has gained national attention for his empathetic treatment of patients and his commitment to offering free online consultations. His actions shed light on the massive disparities in China's healthcare system and the evolving role of PLA medical personnel in civil society.